Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: Problems and progress from the perspective of long-term follow-up

Seminars in Oncology

Volumn 15, Issue 3 SUPPL. 4, 1988, Pages 6-15

  Spain, Robert C ^a  

^a Penrose Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; MITOMYCIN C; VINBLASTINE;

ADULT; AGED; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; PROGNOSIS; SURVIVAL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FOLLOW-UP STUDIES; HUMAN; LUNG; LUNG NEOPLASMS; MIDDLE AGE; MITOMYCIN; MITOMYCINS; VINBLASTINE;

EID: 0023754111     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cancer statistics 1987
2. Surgical aspects: Overview
3. The survival of patients with inoperable lung cancer A large scale randomized study of radiation therapy versus placebo
4. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung
5. Impact of irradiation techniques and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung
6. Non-small cell carcinoma of the lung: Dose-time parameters
7. Patterns of failure in localized unresectable non-oat cell carcinoma of the lung treated by radiation therapy
8. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases
9. Present status of postoperative adjuvant therapy for lung cancer
10. Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy
11. The genetic origin of drug resistance in neoplasms: Implications for systemic therapy
12. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
13. Clinical and scientific considerations in preoperative (neoadjuvant) chemotherapy
14. Prognostic factors for survival in patients with inoperable lung cancer
15. Lung cancer
16. A new international staging system
17. Reporting result of cancer treatment
18. The effect of anemia on diffusing capacity with derivation of a correction equation
19. Nonparametric estimation from incomplete observations
20. A generalized Wilcoxan test for comparing arbitrarily singly censored samples
21. Trial of preoperative cisplatin plus vinca alkaloid chemotherapy in non-small cell lung cancer patients with clinically apparent, ipsilateral, mediastinal lymph node metastases
22. Combined treatment with chemotherapy and neutron irradiation for limited non-small cell lung cancer: A Southwest Oncology Group study
23. Mitomycin, vinblastine and cisplatin combination chemotherapy in non-small cell lung cancer (NSCLC)
24. Phase II trial of mitomycin, vinblastine and cisplatin in non-small cell bronchogenic carcinoma
25. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: est 2575, generation V—A randomized comparison of four cisplatin containing regimens
26. An active chemotherapy regimen for squamous cell lung cancer
27. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine and vinblastine in human patients with cancer
28. Interstitial pneumonia from mitomycin
29. Generation of free radicals of quinone group containing anticancer chemicals in NADPH-microsome systems as evidenced by initiation of sulfite oxidation
30. A general mechanism for microsomal activation of quinone anticancer agents to free radicals
31. Influence of corticosteroids on human polymorphonuclear leukocyte function in vitro
32. Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue bound IgG
33. Comparative adherence of granulocytes to endothelial monolayers and nylon fiber
34. Regulation of matrix accumulation
35. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics
36. Role of Adriamycin-induced hydroxyl radical formation in tumor cell kill
37. Cure of advanced Lewis lung carcinoma: A new treatment strategy